APA (7th ed.) Citation

C, G., AA, M., & NJ, C. (2022). ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of surgical oncology, 29(4), 2614. https://doi.org/10.1245/s10434-021-11021-x

Chicago Style (17th ed.) Citation

C, Godbole, Memon AA, and Carr NJ. "ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy." Annals of Surgical Oncology 29, no. 4 (2022): 2614. https://doi.org/10.1245/s10434-021-11021-x.

MLA (9th ed.) Citation

C, Godbole, et al. "ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy." Annals of Surgical Oncology, vol. 29, no. 4, 2022, p. 2614, https://doi.org/10.1245/s10434-021-11021-x.